Abstract:Objective To observe the short-term efficacy of posterior sub-tenon injection of triamcinolone acetonide (PSTA) in the treatment of macular edema due to ischemic retinal vein occlusions (RVO).Methods A retrospective clinical study.A total of 53 eyes of 53 patients with RVO macular edema diagnosed by fundus color photography,fundus fluorescein angiography and optical coherence tomography (OCT) were included in the study.The best corrected visual acuity (BCVA) was detected by the international standard visual acuity chart,and the results were converted to the logarithm of the minimum angle of resolution (logMAR) visual acuity.The central macular thickness (CMT) was measured by OCT.Among 53 eyes,there were 27 eyes with ischemic RVO maeular edema (ischemic group) and 26 eyes with non-ischemic RVO macular edema (non-ischemic group).The mean logMAR BCVA was 0.82±0.37,mean CMT was (662.1±216.7) μm in ischemic group.The mean logMAR BCVA was 0.41±0.23,mean CMT was (548.0± 161.9) μm.The differences of logMAR BCVA and CMT between the two groups werw both statistically significant (t =4.745,2.258;P＜ 0.05).All eyes were treated with a single sub-Tenon injection of 0.4 ml triamcinolone acetonide suspension (100 mg/ml).The mean logMAR BCVA,CMT before and 1,3 months after the treatment between the two groups were observed and compared.Results On 1 and 3 months after treatment,the mean logMAR BCVA in the non-ischemic group (0.32±0.25 and 0.27±0.29) were improved compared with ischemic group (0.76±0.37 and 0.41±0.79),the difference was statistically significant (t=5.052,5.240;P＜0.05).The mean logMAR BCVA before and after treatment had no statistically significant difference in ischemic group (F=0.516,P＞0.05),but had a statistically significant difference in non-ischemic group (F=7.685,P＜0.05).On 1 and 3 months after treatment,the mean CMT in the ischemic group were (534.7±223.4),(470.8±234.7) μm,which were lower (127.4 ± 28.28),(191.4 ± 34.55) μm before treatment.In the non-ischemic group,the average CMT was (426.2±188.8),(371.3±200.6) μm,which were lower (103.1±33.1),(164.9±49.6) μm.There were statistically significant differences in the mean CMT between the ischemic group and the non ischemic group (F=17.040,10.360;P＜0.05).In non-ischemic group,CMT had a bigger reduction compared to the the ischemic group (t=2.056,2.103;P＜0.05).The difference of CMT decrease value between two groups was not statistically significant (t=0.560,0.441;P＞0.05).On 1 month after the treatment,there were 3 and 5 eyes had a higher intraocular pressure than 21 mmHg (1 mmHg=0.133 kPa) in ischemic and non-ischemic group,respectively;but all of them returned to normal after drug treatment.There were no drugs and ocular injection related complications.Conclusion PSTA of ischemic RVO macular edema can lower the CMT in the short term,but can't significant improve the visual acuity.

Retrobulbar Injection of Triamcinolone Acetonide to Treat Macular Edema Secondary to Branch Retinal Vein Occlusion

Efficacy and safety of post-scleral injection of triamcinolone acetonide for macular edema in branch retinal vein occlusion: 3 month results from a prospective randomized, controlled and open label clinical trial

Intravitreal injection of low-dose triamcinolone acetonide to treat macular edema

Effect of triamcinolone acetonide and laser photocoagulation for macular edema of retinal vein occlusion

Different Dosages of Intravitreal Triamcinolone Acetonide Injections for Macular Edema Secondary to Central Retinal Vein Occlusion.

Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion

Comparision of Intravitreal Triamcinolone Acetonide for Macular Edema Secondary to Retinal Vein Occlusion and Diabetic Retinopathy

Clinical Observation of Intravitreal Injection of Triamcinolone Acetonide for Macular Edema Secondary to Retinal Vein Occlusion

Intravitreal Bevacizumab Versus Triamcinolone Acetonide for Macular Edema Due to Branch Retinal Vein Occlusion: a Matched Study.

Effect of intravitreal injection of Avastin combined with triamicinolone acetonide for treatment of branch retinal vein occlusion and crystal macular edema

Treatment of Triamcinolone Acetonide Intravitreous Injection for Macular Edema

Intravitreal injection of triamcinolone acetonide for chronic cystoid macular edema after cataract operation

Application of Subtenon Injection of Triamcinolone Acetonide Combined with Vitrectomy in the Treatment of Retinal Detachment with Choroidal Detachment

Clinical observation of retrobulbar injection of triamcinolone acetonide combined 577 nm laser macular grid photocoagulation for the treatment of cystoid macular edema

Intravitreal Triamcinolone Versus Bevacizumab for the Treatment of Macular Edema in Retinal Vein Occlusion

Intravitreal injection of triamcinolone acetonide for diffuse diabetic macular edema

Treatmemt of Ischemic Central Retinal Vein Occlusion by Argon Laser Photocoagulation Combined with Intravitreous Injection of Triamcinolone Acetonide

Comparative Research of Intravitreal Bevacizumab Versus Triamcinolone Treatment for Macular Edema in Retinal Vein Occlusion

A prospective randomized clinical trial on intravitreous injection of Conbercept combined with laser photocoagulation for macular edema secondary to branch retinal vein occlusion

Clinical Effect of Intravitreous Injection of Triamcinolone Acetonide in Treating Cystoid Macular Edema

Short-term Efficacy of Posterior Sub-Tenon Injection of Triamcinolone Acetonide in Macular Edema Due to Ischemic Retinal Vein Occlusions